Back to Search
Start Over
How public health services pay for radiotherapy in Europe:an ESTRO-HERO analysis of reimbursement
- Source :
- Lievens, Y, Defourny, N, Corral, J, Gasparotto, C, Grau, C, Borras, J M & ESTRO–HERO Consortium Collaborators 2020, ' How public health services pay for radiotherapy in Europe : an ESTRO-HERO analysis of reimbursement ', The Lancet Oncology, vol. 21, no. 1, pp. e42-e54 . https://doi.org/10.1016/S1470-2045(19)30794-6
- Publication Year :
- 2020
-
Abstract
- Reimbursement is a key factor in defining which resources are made available to ensure quality, efficiency, availability, and access to specific health-care interventions. This Policy Review assesses publicly funded radiotherapy reimbursement systems in Europe. We did a survey of the national societies of radiation oncology in Europe, focusing on the general features and global structure of the reimbursement system, the coverage scope, and level for typical indications. The annual expenditure covering radiotherapy in each country was also collected. Most countries have a predominantly budgetary-based system. Variability was the major finding, both in the components of the treatment considered for reimbursement, and in the fees paid for specific treatment techniques, fractionations, and indications. Annual expenses for radiotherapy, including capital investment, available in 12 countries, represented between 4·3% and 12·3% (average 7·8%) of the cancer care budget. Although an essential pillar in multidisciplinary oncology, radiotherapy is an inexpensive modality with a modest contribution to total cancer care costs. Scientific societies and policy makers across Europe need to discuss new strategies for reimbursement, combining flexibility with incentives to improve productivity and quality, allowing radiation oncology services to follow evolving evidence.
- Subjects :
- medicine.medical_specialty
media_common.quotation_subject
Psychological intervention
030218 nuclear medicine & medical imaging
Reimbursement Mechanisms
03 medical and health sciences
0302 clinical medicine
Multidisciplinary approach
Neoplasms
Medicine
Humans
Quality (business)
Productivity
Reimbursement
media_common
Health Services Needs and Demand
Actuarial science
Scope (project management)
Radiotherapy
business.industry
Public health
Health Services
Europe
Incentive
Oncology
030220 oncology & carcinogenesis
Public Health
business
Delivery of Health Care
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Lievens, Y, Defourny, N, Corral, J, Gasparotto, C, Grau, C, Borras, J M & ESTRO–HERO Consortium Collaborators 2020, ' How public health services pay for radiotherapy in Europe : an ESTRO-HERO analysis of reimbursement ', The Lancet Oncology, vol. 21, no. 1, pp. e42-e54 . https://doi.org/10.1016/S1470-2045(19)30794-6
- Accession number :
- edsair.doi.dedup.....8429be168c8a7b9fdebde73bc35cdcc0
- Full Text :
- https://doi.org/10.1016/S1470-2045(19)30794-6